Common Stock, Shares, Outstanding of Moleculin Biotech, Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Moleculin Biotech, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • Moleculin Biotech, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 49,498,576, a 1549% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Moleculin Biotech, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 49,498,576 +46,496,681 +1549% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 30,207,494 +27,646,709 +1080% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 14,127,494 +11,815,958 +511% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 3,378,895 +1,151,379 +52% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 3,001,895 -26,808,548 -90% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 2,560,785 -27,228,537 -91% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 2,311,536 -27,288,787 -92% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 2,227,516 +318,993 +17% 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 29,810,443 +1,182,616 +4.1% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 29,789,322 +1,182,616 +4.1% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 29,600,323 +1,021,985 +3.6% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 1,908,523 -26,669,815 -93% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 28,627,827 +50,739 +0.18% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 28,606,706 +54,493 +0.19% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 28,578,338 +133,913 +0.47% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 28,578,338 +17,041,618 +148% 31 Dec 2021 10-Q 10 Nov 2022 2022 Q3
Q3 2021 28,577,088 -33,187,137 -54% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 28,552,213 -31,850,951 -53% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 28,444,425 -24,783,275 -47% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 11,536,720 +3,915,382 +51% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 61,764,225 +16,036,525 +35% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 60,403,164 +15,206,116 +34% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 53,227,700 +18,818,670 +55% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 7,621,338 -20,907,325 -73% 31 Dec 2019 10-K 24 Mar 2021 2020 FY
Q3 2019 45,727,700 +18,866,203 +70% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 45,197,048 +18,335,551 +68% 30 Jun 2019 10-Q 16 Aug 2019 2019 Q2
Q1 2019 34,409,030 +8,640,169 +34% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 28,528,663 +7,059,554 +33% 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q3 2018 26,861,497 +6,039,283 +29% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 26,861,497 +6,696,643 +33% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 25,768,861 +8,011,999 +45% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 21,469,109 +9,304,257 +76% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q3 2017 20,822,214 +8,767,401 +73% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 20,164,854 +8,910,098 +79% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 17,756,862 +10,967,029 +162% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 12,164,852 +5,503,852 +83% 31 Dec 2016 10-K 28 Mar 2018 2017 FY
Q3 2016 12,054,813 30 Sep 2016 10-Q 21 Nov 2016 2016 Q3
Q2 2016 11,254,756 30 Jun 2016 10-Q 21 Nov 2016 2016 Q2
Q1 2016 6,789,833 31 Mar 2016 10-Q 16 Jun 2016 2016 Q1
Q4 2015 6,661,000 31 Dec 2015 10-K 03 Apr 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.